Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.11K Buy
+23
New +$1.17K ﹤0.01% 418
2022
Q2
– Sell
-380
Closed -$21K – 220
2022
Q1
$21K Buy
+380
New +$20.6K 0.01% 233

Other funds holding GSK

DeDora Capital's GSK Position: Q3 2026 in Review

DeDora Capital opened a new position in GSK (GSK) in Q3 2026: 23 shares worth $1.11K. The stake represents ﹤0.01% of the portfolio and ranks #418 among its holdings. This is a return to the name: DeDora Capital previously reported a position in GSK as recently as Q1 2022.

DeDora Capital first reported a position in GSK in Q1 2022 and has held it in 2 quarters since. The position peaked at $21K in Q1 2022. 989 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • DeDora Capital held 23 shares of GSK worth $1.11K as of Q3 2026.
  • GSK was a new DeDora Capital position in Q3 2026.
  • GSK made up ﹤0.01% of DeDora Capital's portfolio in Q3 2026, its #418 holding.
  • DeDora Capital first reported a position in GSK in Q1 2022 and has held it in 2 quarters since.
  • DeDora Capital's GSK position peaked at $21K in Q1 2022.
  • 989 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on DeDora Capital's 13F filing for Q3 2026, filed 26 Oct 2026.